Literature DB >> 10071083

Myelodysplastic syndrome: a search for minimal diagnostic criteria.

F Ramos1, S Fernández-Ferrero, D Suárez, M Barbón, J A Rodríguez, S Gil, M Megido, J Ciudad, N López, C del Cañizo, A Orfao.   

Abstract

We have evaluated dyshemopoietic features in bone marrow (BM) samples obtained from healthy people aged over 50 without peripheral blood (PB) cytopenia patients and compared them with MDS patients. Control group displayed BM features of dyserythropoiesis and dysgranulopoiesis in up to 15 and 27% of the considered cell elements (P90) respectively, overlapping in part with MDS patients. Interobserver agreement in dyshemopoietic features was highest for BM blast cell and pathological sideroblast counts. An algorithm based on BM blast cell and pathological sideroblast counts that has been verified on 613 patients from different Spanish centers may be of help to improve reproducibility in Myelodysplastic syndrome (MDS) diagnosis.

Entities:  

Mesh：

Year:  1999        PMID： 10071083     DOI： 10.1016/s0145-2126(98)00166-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  12 in total

1.  Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.

Authors:  Stefani Parmentier; Johannes Schetelig; Kerstin Lorenz; Michael Kramer; Robin Ireland; Ulrich Schuler; Rainer Ordemann; Gabi Rall; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Frank Kroschinsky
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease.

Authors:  Manuel Aivado; Dimitrios Spentzos; Ulrich Germing; Gil Alterovitz; Xiao-Ying Meng; Franck Grall; Aristoteles A N Giagounidis; Giannoula Klement; Ulrich Steidl; Hasan H Otu; Akos Czibere; Wolf C Prall; Christof Iking-Konert; Michelle Shayne; Marco F Ramoni; Norbert Gattermann; Rainer Haas; Constantine S Mitsiades; Eric T Fung; Towia A Libermann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-12       Impact factor: 11.205

3.  Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.

Authors:  Matteo G Della Porta; Cristina Picone; Cristiana Pascutto; Luca Malcovati; Hideto Tamura; Hiroshi Handa; Magdalena Czader; Sylvie Freeman; Paresh Vyas; Anna Porwit; Leonie Saft; Theresia M Westers; Canan Alhan; Claudia Cali; Arjan A van de Loosdrecht; Kiyoyuki Ogata
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

4.  Inter-observer agreement in myelodysplastic syndromes.

Authors:  Fernando Ramos; Silvia Fernández-Ferrero
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

5.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

Review 6.  Genetics of progression from MDS to secondary leukemia.

Authors:  Andrew J Menssen; Matthew J Walter
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

7.  Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Authors:  M G Della Porta; E Travaglino; E Boveri; M Ponzoni; L Malcovati; E Papaemmanuil; G M Rigolin; C Pascutto; G Croci; U Gianelli; R Milani; I Ambaglio; C Elena; M Ubezio; M C Da Via'; E Bono; D Pietra; F Quaglia; R Bastia; V Ferretti; A Cuneo; E Morra; P J Campbell; A Orazi; R Invernizzi; M Cazzola
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

8.  Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.

Authors:  Sara A Monaghan; Lijun Dai; Markus Y Mapara; Daniel P Normolle; Susanne M Gollin; Suzanne Lentzsch
Journal:  Leuk Lymphoma       Date:  2013-01-28

9.  Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.

Authors:  Nobutaka Kawai; Akira Matsuda; Itsuro Jinnai; Takaya Ichimura; Hidekazu Kayano; Daisuke Okamura; Maho Ishikawa; Tomoya Maeda; Tomoko Hata; Yasushi Miyazaki; Norio Asou; Masami Bessho; Masao Tomonaga
Journal:  Int J Hematol       Date:  2015-11-25       Impact factor: 2.490

Review 10.  Importance of classical morphology in the diagnosis of myelodysplastic syndrome.

Authors:  Rosangela Invernizzi; Federica Quaglia; Matteo Giovanni Della Porta
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.